Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT00105560
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed medulloblastoma or pineoblastoma
* Standard-risk or high-risk disease
* Must have undergone biopsy or attempted surgical resection of the tumor within the past 35 days
* Requires craniospinal irradiation
PATIENT CHARACTERISTICS:
Age
* 3 to 21
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No more than 1 prior chemotherapy regimen
* No prior IV or intrathecal methotrexate
* No prior intrathecal thiotepa
* Concurrent cisplatin-based chemotherapy, including chemotherapy administered on another study, allowed
Endocrine therapy
* Not specified
Radiotherapy
* No prior radiotherapy
Surgery
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
21 Years
Study:
NCT00105560
Study Brief:
Protocol Section:
NCT00105560